Who
Sean F. Moran
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Corbus Pharmaceuticals Holdings; Acting Chief Financial Officer, Invivo Therapeutics Holdings; Chief Financial Officer, Imunon.
In numbers
- Trades disclosed
- 113
- Buys
- 49
- Sells
- 12
- Bought
- $1.3M
- Sold
- $1.8M
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 8 Dec 2008
- Last trade
- 7 Aug 2026
- Last filed
- 10 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Aug 2026filed 10 Aug 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $121K12,000 at $10.08 | filing |
| 7 Aug 2026filed 10 Aug 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $121K12,000 at $10.08 | filing |
| 13 Feb 2026filed 18 Feb 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $37K4,701 at $7.78 | filing |
| 13 Feb 2026filed 18 Feb 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $37K4,701 at $7.78 | filing |
| 14 Jan 2026filed 16 Jan 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —28,082 at $0.00 | filing |
| 14 Jan 2026filed 16 Jan 2026 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —84,247 at $0.00 | filing |
| 14 Jan 2026filed 16 Jan 2026 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —84,247 at $0.00 | filing |
| 14 Jan 2026filed 16 Jan 2026 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —28,082 at $0.00 | filing |
| 24 Oct 2025filed 27 Oct 2025 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,981 at $0.00 | filing |
| 24 Oct 2025filed 27 Oct 2025 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code M | $55K12,981 at $4.26 | filing |
| 24 Oct 2025filed 27 Oct 2025 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $221K12,981 at $17.02 | filing |
| 14 Feb 2025filed 18 Feb 2025 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $24K2,792 at $8.76 | filing |
| 31 Jan 2025filed 4 Feb 2025 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —92,500 at $0.00 | filing |
| 31 Jan 2025filed 4 Feb 2025 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code A | —27,500 at $0.00 | filing |
| 18 Jun 2024filed 18 Jun 2024 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,958 at $0.00 | filing |
| 18 Jun 2024filed 18 Jun 2024 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code M | $59K1,958 at $30.00 | filing |
| 18 Jun 2024filed 18 Jun 2024 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $82K1,958 at $42.12 | filing |
| 17 Jun 2024filed 18 Jun 2024 | CRBP Corbus Pharmaceuticals Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,730 at $0.00 | filing |
| 17 Jun 2024filed 18 Jun 2024 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Code M | $95K6,730 at $14.10 | filing |
| 17 Jun 2024filed 18 Jun 2024 | CRBP Corbus Pharmaceuticals HoldingsBiotechnology | SEC FORM 4 Sold | $315K6,730 at $46.77 | filing |
News
No headline names them, or the companies they trade most, lately.